Hereditary angioedema - Treatment;Dziedziczny obrzek naczynioruchowy - Leczenie

Polski Merkuriusz Lekarski

Volumn 25, Issue 145, 2008, Pages 94-96

  Muszyńska, Agnieszka ^a   Fal, Andrzej M ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Department of Internal Diseases and Allergology ^*

Author keywords

C1 inhibitor's deficiency; Hereditary angioedema; Treatment

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; DRUG DERIVATIVE; ICATIBANT; KALLIKREIN; RECOMBINANT PROTEIN;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; DRUG ANTAGONISM; FEMALE; HUMAN; MALE; METHODOLOGY; PRIMARY PREVENTION;

ADULT; ANGIOEDEMA, HEREDITARY; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; KALLIKREINS; MALE; PRIMARY PREVENTION; RECEPTORS, BRADYKININ; RECOMBINANT PROTEINS;

EID: 49949086518     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Berkun Y., Haut M.: Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor. Ann. Allergy Asth. Immunol., 2001, 87, 138-139.
2. Bork K., Pitton M., Harten P., Koch P.: Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet, 1999, 353, 1066-1067.
3. Bork K., Barnstedt S.E.: Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch. Intern.Med., 2001, 161, 714-718.
4. Brackertz D., Kueppers F.: Hereditary angioneurotic oedema. Lancet, 1973, 2, 680.
5. Cicardi M., Castelli R., Zingale L.C., Agostoni A.: Side effects of longterm prophylaxis with attenuated androgens in hereditary angioedema, comparison of treated and untreated patients. J. Allergy Clin. Immunol., 1997, 99, 194-196.
6. Cicardi M., Zingale L.: How do we treat patients with hereditary angioedema. Transfus. Apheresis Sci., 2003, 29, 221-227.
7. Crampon D., Barnoud R., Durand M., Ponard D., Jacquot C., Sotto J.J. i wsp.: Danazol therapy, an unusual aetiology of hepatocellular carcinoma. J. Hepatol., 1998, 29, 1035-1036.
8. Donaldson V.H. and Evans R.R.: A Biochemical Abnormality in Hereditary Angioneurotic Edema. Absence of Serum Inhibitor of C1 Esterase. Am. J. Sci., 1963, 31, 37.
9. Van Doom M.B., Burggraaf J., van Dam T., Eerenberg A.: A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J. Allergy Clin, Immunol., 2005, 116(4), 876-883.
10. Frank M.M., Sergent U.S., Kane M.A., Ailing D.W.: Epsilon aminocaproic acid therapy of hereditary angioneurotic edema, a double blind study. N. Engl. J. Med., 1972, 286, 808-812.
11. Frank N.M., Gelfand J.A., Atkinson J.P.: Hereditary angioedema. The clinical syndrome and its management. Ann. Intern. Med., 1976, 84, 580-593.
12. Gelfand J.A., Sherins RJ., Ailing D.W., Frank M.M.: Treatment of hereditary angioedema with danazol, reversal of clinical and biochemical abnormalities. N. Engl. J. Med., 1976, 295, 1444-1448.
13. Compels M.M. i wsp.: Ci inhibitor deficiency, consensus document. Clin. Experim. Immunol., 2005, 139 (3), 379-394.
14. Kaplan A.P., Greaves M.W.: Angioedema. J. Am. Acad. Dermatol., 2005, 53(5), 373-388.
15. Karlis V., Glickman R.S., Stern R., Kinney L.: Hereditary angioedema, case report and review of management. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1997, 83, 462-464.
16. Nuijens J., van Doom M., van Dam T., Burggraaf K., Levi M., Hack E. i wsp.: A phase I study of recombinant human C1-INH in asymptomatic patients with hereditary angioedema-HAE. Int. Immunopharmacol., 2002, 2, 1315-1316 (abstrakt).
17. Obtutowicz K.: Obrzeknaczynioruchowy- trudny problem kliniczny. Alert. Astma i Immunol., 2006, 11, supl.1, 166-171.
18. Pickering R.J., Good R.A., Kelly J.R., Gewurz H.: Replacement therapy in hereditary angioedema, successful treatment of two patients with fresh frozen plasma. Lancet, 1969, 1, 326-330.
19. Sim T.C., Grant J.A.: Hereditary angioedema, its diagnostic and management perspectives. JAMA, 1990, 88, 656-664.
20. Watson R.D., Gershwin M.E.: Acquired angioedema associated with sinusitis. J. Invest. Allergol. Clin, Immunol., 2000, 10, 129-134.
21. http://www.dyax.com/clinically/hereditaryang.html/.
22. http://www.jerini.com/site/EN/int/02-drug-pipeline/02_02-icatibant/ container-icatibant.php/.